Business Context and Reporting Period
This Form 6-K filing by Smith & Nephew plc, dated July 21, 2025, serves as a timing announcement for the company's upcoming financial results. Smith & Nephew is a global medical technology company focused on orthopaedics, sports medicine, ENT, and advanced wound management, operating in approximately 100 countries with 17,000 employees. The filing references the period ended June 28, 2025, for which results are pending.
Key Financial Metrics
The filing does not provide specific financial data for the second quarter or first half of 2025, as these results have not yet been released. The only historical financial metric provided is the annual sales figure for 2024, which was $5.8 billion. No data regarding profit, cash flow, margins, debt, or liquidity is present in this document.
Material Changes
No material changes to financial performance are reported in this filing. The document solely announces the schedule for the release of future results and reiterates the company's operational focus and purpose.
Guidance, Outlook, and Risks
Outlook and Guidance: The filing contains no specific financial guidance or quantitative outlook for the upcoming period. It notes that the company will announce second quarter and first half 2025 results on Tuesday, August 5, 2025, at 7:00 am BST / 2:00 am EDT, followed by a conference call at 8:30 am BST / 3:30 am EDT.
Risks and Contingencies: The document includes a comprehensive list of forward-looking statement risks, including:
- Conflicts in Europe and the Middle East.
- Economic conditions affecting healthcare providers and payers.
- Regulatory approvals, reimbursement decisions, and government actions.
- Product defects, recalls, and quality management failures.
- Supply chain disruptions and cybersecurity threats.
- Foreign exchange volatility and changes in taxation regulations.
- Integration risks related to acquisitions and disposals.
Investor Verification Checklist
- Verify the release of the official Q2 and H1 2025 results on August 5, 2025.
- Confirm the details of the conference call on the Smith & Nephew investor website.
- Review the upcoming Form 20-F for detailed risk factors and historical financial data.
- Monitor for any updates regarding the $5.8 billion 2024 sales baseline in the context of 2025 performance.